Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.79 USD | +1.62% |
|
+10.71% | +29.46% |
Jul. 01 | Harte Hanks, Inc.(NasdaqGM:HHS) dropped from Russell Microcap Value Index | CI |
Jul. 01 | Harte Hanks, Inc.(NasdaqGM:HHS) dropped from Russell 3000E Value Index | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its low valuation, with P/E ratio at 11.42 and 6.35 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company shows low valuation levels, with an enterprise value at 0.22 times its sales.
- Sales forecast by analysts have been recently revised upwards.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Advertising & Marketing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+29.46% | 63.65M | - | ||
+3.62% | 2.29B | B- | ||
-32.55% | 459M | - | - | |
+32.42% | 427M | - | - | |
-28.67% | 367M | - | - | |
-4.31% | 137M | C | ||
-49.23% | 116M | - | - | |
+3.74% | 109M | - | - | |
+72.17% | 90.94M | - | ||
+6.73% | 85.85M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- HHS Stock
- Ratings Harte Hanks, Inc.